Systemic proteolytic markers are increased and associate with comorbidities in individuals with COPD and restrictive spirometric pattern

U. Nilsson (Umeå, Sweden), V. Pleiborn (Umeå, Sweden), R. Linder (Umeå, Sweden), H. Backman (Umeå, Sweden), A. Behndig (Umeå, Sweden), A. Lindberg (Umeå, Sweden), A. Blomberg (Umeå, Sweden)

Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases
Session: Mechanism or pathways of chronic lung diseases
Session type: E-poster session
Number: 2067
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
U. Nilsson (Umeå, Sweden), V. Pleiborn (Umeå, Sweden), R. Linder (Umeå, Sweden), H. Backman (Umeå, Sweden), A. Behndig (Umeå, Sweden), A. Lindberg (Umeå, Sweden), A. Blomberg (Umeå, Sweden). Systemic proteolytic markers are increased and associate with comorbidities in individuals with COPD and restrictive spirometric pattern. 2067

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Markers of systemic inflammation are associated with increased symptoms and respiratory exacerbations among smokers with preserved spirometry in SPIROMICS
Source: International Congress 2018 – Biomarkers in COPD and asthma
Year: 2018



Comparison of comorbidities between two different subgroups in combined assessment of COPD
Source: International Congress 2016 – Postural balance, respiratory muscles, and comorbidities in chronic respiratory disease
Year: 2016

Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients
Source: Annual Congress 2011 - COPD: human studies
Year: 2011


A restrictive spirometry pattern is associated with lower physical activity levels in adults
Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function
Year: 2017

Different chronic obstructive pulmonary disease phenotypes, systemic inflammation and the risk of falls
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016


The relationship between comorbidities and systemic inflammation in patients with COPD
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011

Differences in systemic immune function contribute to exacerbation susceptibility in COPD patients
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015


High BMI in severe asthma is associated with co-morbid factors but not with increased airway inflammation or -obstruction
Source: Eur Respir J 2002; 20: Suppl. 38, 406s
Year: 2002

Clinical COPD Questionnaire results depending on the degree of the inflammatory response in patients with COPD combined with hypertension
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021


Physical activity and its determinants in a sample of severe COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 353s
Year: 2003

Metabolic and inflammatory profile in patients with COPD and physical activity.
Source: Virtual Congress 2021 – Pulmonary rehabilitation in asthma and COPD
Year: 2021


Physical activity level in restrictive patients
Source: Annual Congress 2007 - Rehabilitation: measuring, monitoring and maintenance
Year: 2007


Cardio-metabolic profile, function and physical activity in mild-moderate COPD patients
Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD
Year: 2017


Assessment the dependence between nutritional status and functional damage of the lungs as well as prognosis in BODE index in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013

Cardiovascular comorbidities prevails in the early stages of COPD irrespective of predominant airway or emphysema phenotype
Source: Annual Congress 2013 –COPD treatment
Year: 2013

The evaluation of different factors that cause FEV1 decline in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 135s
Year: 2001

Comparison of spirometric markers of severity and reversibility in patients with asthma and/or COPD in NOVELTY
Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases
Year: 2020




Cardiac chambers and hyperinflation in COPD patients
Source: Annual Congress 2013 –Clinical physiology and functional imaging in health and disease
Year: 2013


Prevalence and risk factors of co-morbidities in subjects with mild and moderate COPD detected by screening
Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation
Year: 2013


The correlation between lung sound distribution and pulmonary function in COPD patients is influenced by emphysematous lesions
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014